Seascape Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.68M | Sell |
34,322
-694
| -2% | -$54.3K | 0.85% | 46 |
|
|
2025
Q1 | $2.54M | Buy |
35,016
+754
| +2% | +$54.7K | 0.89% | 41 |
|
|
2024
Q4 | $2.54M | Buy |
34,262
+1,273
| +4% | +$94.2K | 0.88% | 44 |
|
|
2024
Q3 | $2.18M | Buy |
32,989
+174
| +0.5% | +$11.5K | 0.78% | 47 |
|
|
2024
Q2 | $3.03M | Buy |
32,815
+1,658
| +5% | +$153K | 1.13% | 33 |
|
|
2024
Q1 | $2.98M | Buy |
31,157
+3,391
| +12% | +$324K | 1.11% | 34 |
|
|
2023
Q4 | $2.12M | Buy |
27,766
+170
| +0.6% | +$13K | 0.89% | 43 |
|
|
2023
Q3 | $1.91M | Buy |
27,596
+604
| +2% | +$41.8K | 0.91% | 39 |
|
|
2023
Q2 | $2.55M | Sell |
26,992
-507
| -2% | -$47.8K | 1.21% | 35 |
|
|
2023
Q1 | $2.28M | Sell |
27,499
-58
| -0.2% | -$4.8K | 1.16% | 39 |
|
|
2022
Q4 | $2.06M | Buy |
27,557
+460
| +2% | +$34.3K | 1.12% | 41 |
|
|
2022
Q3 | $2.24M | Buy |
27,097
+333
| +1% | +$27.5K | 1.53% | 27 |
|
|
2022
Q2 | $2.55M | Buy |
26,764
+68
| +0.3% | +$6.47K | 1.54% | 27 |
|
|
2022
Q1 | $3.14M | Sell |
26,696
-966
| -3% | -$114K | 1.63% | 24 |
|
|
2021
Q4 | $3.58M | Buy |
27,662
+228
| +0.8% | +$29.5K | 1.68% | 21 |
|
|
2021
Q3 | $3.11M | Buy |
27,434
+620
| +2% | +$70.2K | 1.59% | 20 |
|
|
2021
Q2 | $2.78M | Sell |
26,814
-327
| -1% | -$33.9K | 1.45% | 22 |
|
|
2021
Q1 | $2.27M | Sell |
27,141
-2,639
| -9% | -$221K | 1.26% | 33 |
|
|
2020
Q4 | $2.72M | Sell |
29,780
-90
| -0.3% | -$8.21K | 1.59% | 16 |
|
|
2020
Q3 | $2.38M | Sell |
29,870
-384
| -1% | -$30.6K | 1.51% | 14 |
|
|
2020
Q2 | $2.09M | Buy |
+30,254
| New | +$2.09M | 1.5% | 17 |
|